中西医联合治疗喘息型支气管炎80例临床疗效观察

Observation on the Clinical Effect of Therapy of Integrated Medicine in the Treatment of Asthmatic Bronchitis for 80 Cases

目的探讨喘息型支气管炎采用中西医联合治疗临床效果。方法选取喘息型支气管炎患者160例,均为我院2014年2月—2016年2月收治,采用数字表抽取法随机分组,就西医常规治疗(对照组80例)与中西医联合治疗(观察组80例)效果展开对比。结果观察组患者近期总有效率为97.5%,明显高于对照组85.0%;远期总有效率为85.0%,明显高于对照组62.5%,差异均有统计学意义(P<0.05)。两组肺通气功能在治疗前无差异(P>0.05),治疗1周后,均有改善(P<0.05),且观察组较对照组改善幅度更为显著(P<0.05)。两组均无严重不良反应发生。结论针对临床收治的喘息型支气管炎患者,采用中西医联合治疗,可显著提高临床效果,促肺通气功能改善。

Objective To discuss the clinical effect of therapy of integrated medicine in the treatment of asthmatic bronchitis. Methods Selecting 160 cases of patients with asthmatic bronchitis in our hospital from February 2014 to February 2016, they were randomized to conventional Western medicine treatment （ control group, n = 80） and combination therapy of traditional Chinese and Western medicine （observation group, n = 80） by using a digital meter extraction method. The therapeutic effect was compared. Results The recent overall effective rate of the observation group was 97.5% which was significantly higher than 85.0% of the control group, the long-term the total effective rate of the observation group was 85.0% which was significantly higher than 62.5% of the control group, and the difference was statistical significance （P 〈 0. 05）. The pulmonary function of the two groups had no difference before treatment （P 〉 0.05）. After 1 week of treatment, pulmonary function of the two groups were improved （P 〈 0. 05 ） , comparing with specific values, the improved magnitude of the observation group was higher than that of the control group （ P 〈 0. 05 ）. There were no serious adverse events. Conclusion For asthmatic bronchitis patients, therapy of integrated medicine can significantly improve clinical effect, and promote pulmonary function.